These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35065824)

  • 1. Cost-effectiveness of home-based stroke rehabilitation across Europe: A modelling study.
    Candio P; Violato M; Luengo-Fernandez R; Leal J
    Health Policy; 2022 Mar; 126(3):183-189. PubMed ID: 35065824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Effectiveness of Mechanical Thrombectomy for Treatment of Nonminor Ischemic Stroke Across Europe.
    Candio P; Violato M; Leal J; Luengo-Fernandez R
    Stroke; 2021 Jan; 52(2):664-673. PubMed ID: 33423511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.
    Shaw L; Bhattarai N; Cant R; Drummond A; Ford GA; Forster A; Francis R; Hills K; Howel D; Laverty AM; McKevitt C; McMeekin P; Price C; Stamp E; Stevens E; Vale L; Rodgers H
    Health Technol Assess; 2020 May; 24(24):1-202. PubMed ID: 32468989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke rehabilitation pathways during the first year: A cost-effectiveness analysis from a cohort of 460 individuals.
    Barbosa PM; Szrek H; Ferreira LN; Cruz VT; Firmino-Machado J
    Ann Phys Rehabil Med; 2024 May; 67(4):101824. PubMed ID: 38518399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of a phase III international randomised controlled trial of very early mobilisation after stroke (AVERT).
    Gao L; Sheppard L; Wu O; Churilov L; Mohebbi M; Collier J; Bernhardt J; Ellery F; Dewey H; Moodie M;
    BMJ Open; 2019 May; 9(5):e026230. PubMed ID: 31118178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation.
    Wilson RD; Murray PK
    Arch Phys Med Rehabil; 2005 Oct; 86(10):1941-8. PubMed ID: 16213235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of a home-based stroke rehabilitation programme: a cost-effectiveness study.
    Allen L; John-Baptiste A; Meyer M; Richardson M; Speechley M; Ure D; Markle-Reid M; Teasell R
    Disabil Rehabil; 2019 Aug; 41(17):2060-2065. PubMed ID: 29631453
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost effectiveness of the occupation-based approach for subacute stroke patients: result of a randomized controlled trial.
    Nagayama H; Tomori K; Ohno K; Takahashi K; Nagatani R; Izumi R; Moriwaki K; Yamauchi K
    Top Stroke Rehabil; 2017 Jul; 24(5):337-344. PubMed ID: 28198661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Societal value of stem cell therapy in stroke--a modeling study.
    Svensson J; Ghatnekar O; Lindgren A; Lindvall O; Norrving B; Persson U; Kokaia Z
    Cerebrovasc Dis; 2012; 33(6):532-9. PubMed ID: 22571941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cluster randomised controlled trial and economic evaluation of a structured training programme for caregivers of inpatients after stroke: the TRACS trial.
    Forster A; Dickerson J; Young J; Patel A; Kalra L; Nixon J; Smithard D; Knapp M; Holloway I; Anwar S; Farrin A;
    Health Technol Assess; 2013 Oct; 17(46):1-216. PubMed ID: 24153026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Burden and Cost-Effective Analysis of the Nationwide Implementation of the Quality in Acute Stroke Care Protocol in Australia.
    Marquina C; Ademi Z; Zomer E; Ofori-Asenso R; Tate R; Liew D
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105931. PubMed ID: 34157669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AbobotulinumtoxinA and rehabilitation vs rehabilitation alone in post-stroke spasticity: A cost-utility analysis.
    Lazzaro C; Baricich A; Picelli A; Caglioni PM; Ratti M; Santamato A
    J Rehabil Med; 2020 Feb; 52(2):. PubMed ID: 31820010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structured training programme for caregivers of inpatients after stroke (TRACS): a cluster randomised controlled trial and cost-effectiveness analysis.
    Forster A; Dickerson J; Young J; Patel A; Kalra L; Nixon J; Smithard D; Knapp M; Holloway I; Anwar S; Farrin A;
    Lancet; 2013 Dec; 382(9910):2069-76. PubMed ID: 24054816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke rehabilitation services to accelerate hospital discharge and provide home-based care: an overview and cost analysis.
    Anderson C; Ni Mhurchu C; Brown PM; Carter K
    Pharmacoeconomics; 2002; 20(8):537-52. PubMed ID: 12109919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of nurse-led stroke aftercare addressing long-term psychosocial outcome: a comparison to care-as-usual.
    Verberne DPJ; van Mastrigt GAPG; Ponds RWHM; van Heugten CM; Kroese MEAL
    BMJ Open; 2021 Feb; 11(2):e039201. PubMed ID: 33632749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative analysis of models used to evaluate the cost-effectiveness of dabigatran versus warfarin for the prevention of stroke in atrial fibrillation.
    Sorensen SV; Peng S; Monz BU; Bradley-Kennedy C; Kansal AR
    Pharmacoeconomics; 2013 Jul; 31(7):589-604. PubMed ID: 23615895
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.